Deutsch English Français

Contact

EP0759299

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0759299

EP0759299 - Potentiation of serotonin response [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 23.02.2001 Database last updated on 24.08.2024
Most recent event Tooltip	23.02.2001	No opposition filed within time limit	published on 11.04.2001 [2001/15]
Applicant(s)	For all designated states ELI LILLY AND COMPANY Lilly Corporate Center Indianapolis, IN 46285 / US
	[N/P]
Former [1997/09]	For all designated states ELI LILLY AND COMPANY Lilly Corporate Center Indianapolis, Indiana 46285 / US
Inventor(s)	01 / Wong, David Taiwai 5812 East Fall Creek Parkway North Drive Indianapolis, Indiana 46226 / US
	[1997/09]
Representative(s)	Hudson, Christopher Mark, et al Lilly Industries Limited European Patent Operations Erl Wood Manor Windlesham Surrey GU20 6PH / GB
	[N/P]
Former [1997/09]	Hudson, Christopher Mark, et al Lilly Industries Limited European Patent Operations Erl Wood Manor Windlesham Surrey GU20 6PH / GB
Application number, filing date	96305999.3	16.08.1996
	[1997/09]
Priority number, date	US19950002440	16.08.1995 Original published format: US 2440
	[1997/09]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP0759299
	Date:	26.02.1997
	Language:	EN
	[1997/09]
	Type:	B1 Patent specification
	No.:	EP0759299
	Date:	26.04.2000
	Language:	EN
	[2000/17]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	02.12.1996
Classification	IPC:	A61K31/505, A61K45/06, // (A61K31/505, 31:135),(A61K31/505, 31:145),(A61K31/505, 31:34),(A61K31/505, 31:38),(A61K31/505, 31:40),(A61K31/505, 31:445)	[1997/09]
	CPC:	A61K45/06 (EP); A61K31/505 (EP)
	C-Set:	A61K31/505, A61K2300/00 (EP); A61K31/505, A61K31/135 (EP); A61K31/505, A61K31/145 (EP); A61K31/505, A61K31/34 (EP); (+) A61K31/505, A61K31/38 (EP); A61K31/505, A61K31/40 (EP); A61K31/505, A61K31/445 (EP) (-)
Designated contracting states	AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1997/09]
Title	German:	Potenzierung von Serotonin-Wirkstoffresponz	[1997/09]
	English:	Potentiation of serotonin response	[1997/09]
	French:	Potentialisation de la sérotonine	[1997/09]
Examination procedure	26.08.1996	Examination requested [1997/09]
	29.10.1998	Despatch of a communication from the examining division (Time limit: M06)
	14.06.1999	Reply to a communication from the examining division
	17.06.1999	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	09.08.1999	Despatch of communication of intention to grant (Approval: No)
	04.10.1999	Despatch of communication of intention to grant (Approval: later approval)
	26.10.1999	Communication of intention to grant the patent
	10.01.2000	Fee for grant paid
	10.01.2000	Fee for publishing/printing paid
Opposition(s)	27.01.2001	No opposition filed within time limit [2001/15]
Request for further processing for:	18.06.1999	Request for further processing filed
	14.06.1999	Full payment received (date of receipt of payment) Request granted
	29.06.1999	Decision despatched
	17.06.1999	Request for further processing filed
	14.06.1999	Full payment received (date of receipt of payment) Request deemed not to be filed
	29.06.1999	Decision despatched
	14.06.1999	Request for further processing filed
	14.06.1999	Full payment received (date of receipt of payment) Request deemed not to be filed
	29.06.1999	Decision despatched
Fees paid	Renewal fee
	04.07.1998	Renewal fee patent year 03
	10.08.1999	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[PX]EP0687472 (LILLY CO ELI [US]) [PX] 15 * pages 2-8; claims 1-15 * * pages 11-13 *;
		[PX]EP0714663 (LILLY CO ELI [US]) [PX] 15 * pages 2-7; claims 1-11 * * pages 9-12 *;
		[X] - ARNT, HYTTEL, LARSEN, "THE CITALOPRAM / 5-HTP INDUCED HEAD SHAKE SYNDROME IS CORRELATED TO 5-HT2 RECEPTOR AFFINITY AND ALSO INFLUENCED BY OTHER TRANSMITTERS", ACTA PHARMACOLOGICA ET TOXICOLOGICA, (1984), vol. 55, pages 363 - 372, XP000607318 [X] 1,2,8,9,13-15 * pages 367-369; tables 1-3 *
		[XA] - HJORTH, AUERBACH, "FURTHER EVIDENCE FOR THE IMPORTANCE OF 5-HT1A AUTORECEPTORS IN THE ACTION OF SSRI", EUROPEAN JOURNAL OF PHARMACOLOGY, (1994), vol. 260, pages 251 - 255, XP000605645 [X] 15 * page 254, column L * [A] 1-14 DOI: http://dx.doi.org/10.1016/0014-2999(94)90346-8
		[XA] - ARTIGAS ET AL, "PINDOLOL INDUCES A RAPID IMPROVEMENT OF DEPRESSED PATIENTS TREATED WITH SEROTONIN REUPTAKE INHIBITORS", ARCHIVES OF GENERAL PSYCHIATRY, (1994), vol. 51, no. 3, pages 248 - 251, XP000605678 [X] 15 * page 249, column L - page 251, column L * [A] 1,2,4,6-9,13,14
		[XA] - GARTSIDE ET AL, "interaction between a selective 5-HT1A receptor antagonist and a SSRI in vivo: Effects ... extracellular 5-HT", BRITISH JOURNAL OF PHARMACOLOGY, (1995), vol. 115, pages 1064 - 1070, XP000604130 [X] 15 * page 1068 - page 1069 * [A] 1-14
		[XA] - HJORTH, "serotonin 5-HT1A autoreceptor blockade potentiates the ability of ... citalopram to increase nerve terminal output of 5-HT ...", JOURNAL OF NEUROCHEMISTRY, (1993), vol. 60, no. 2, pages 776 - 779, XP000604419 [X] 15 * page 777 * * page 779, column L * [A] 1-14 DOI: http://dx.doi.org/10.1111/j.1471-4159.1993.tb03217.x
		[X] - SANCHEZ, HYTTEL, "ISOLATION-INDUCED AGGRESSION IN MICE: EFFECTS OF 5-HT UPTAKE INHIBITORS AND INVOLVEMENT OF POSTSYNAPTIC 5-HT1A RECEPTORS243", EUROPEAN JOURNAL OF PHARMACOLOGY, (1994), vol. 264, pages 241 - 247, XP000607292 [X] 15 * page 243, column R - page 244, column L; table 2 * * page 245, column R - page 246 * DOI: http://dx.doi.org/10.1016/0014-2999(94)00470-6
		[X] - LAHTI, BARSUHN, "THE EFFECT OF ANTIDEPRESSANTS ON L-5HTP-INDUCED CHANGES IN RAT PLASMA CORTICOSTEROIDS", RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, (1980), vol. 28, no. 2, pages 343 - 349, XP000607300 [X] 15 * pages 343-344 *
		[T] - DARMANI, REEVES, "THE MECHANISM BY WHICH THE SELECTIVE 5HT1A RECEPTOR ANTAGONIST (S)-UH-301 PRODUCES HEAD-TWITCHES IN MICE", PHARMACOLOGY BIOCHEMISTRY & BEHAVIOR, (1996), vol. 55, no. 1, pages 1 - 10, XP000607290 [T] 1,2,4,6,8,9,15 DOI: http://dx.doi.org/10.1016/0091-3057(96)00072-X

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p